| 1 |
A Novel CRAd in Combination With Cisplatin Enhanced the Antitumor Efficacy in Ovarian Cancer : |
|
|
| Bei Zhang, Yaowu Liu, Peiying Zhang, Yaqin Wei, Xiaoxing Yin, Junnian Zheng |
|
| International Journal of Gynecological Cancer. 2011; 21(9): 1540 |
|
| [HTML Full text] [Google Scholar] |
|
| 2 |
Bladder tumor markers: From hematuria to molecular diagnostics - Where do we stand? |
|
|
| Shirodkar, S.P., Lokeshwar, V.B. |
|
| Expert Review of Anticancer Therapy. 2008; 8(7): 1111-1123 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Quantitative detection of survivin mRNA expression in breast cancer and its clinical value |
|
|
| Qin, J., Zhang, J., Tang, J., Liu, M., Zhao, J. |
|
| Chinese Journal of Clinical Oncology. 2008; 35(24): 1407-1410 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Molecular markers for bladder cancer: the road to a multimarker approach |
|
|
| Marc Birkhahn, Anirban P Mitra, Richard J Cote |
|
| Expert Review of Anticancer Therapy. 2007; 7(12): 1717-1727 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas |
|
|
| L. Pina-Cabral, L. Santos, B. Mesquita, T. Amaro, S. Magalhăes, B. Criado |
|
| Clinical and Translational Oncology. 2007; 9(11): 731-736 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy |
|
|
| Weiss, C., Rödel, F., Ott, O., Engehausen, D.G., Papadopoulos, T., Sauer, R., Rödel, C. |
|
| Strahlentherapie und Onkologie. 2007; 183(10): 552-556 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer |
|
|
| Yanbo Wang, Zhaohui Zhu, Fuqing Zeng, Liang Wang, Yu Wu, Wei Xia, Shi’an Xing |
|
| Journal of Huazhong University of Science and Technology. 2007; 27(4): 444-447 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition? |
|
|
| Wuttig, D., Kunze, D., Fuessel, S., Toma, M., Stade, J., Kotzsch, M., Kappler, M., (...), Wirth, M.P. |
|
| International Journal of Oncology. 2007; 30(6): 1317-1324 |
|
| [Pubmed] [Google Scholar] |
|
